BLOODGENETICS gets an ENISA loan for young entrepreneurs!! ENISA depends on the Spanish Ministry of industry, trade and tourism and gives financial support to small and middle-sized companies with transformation potential, which are committed to entrepreneurship and innovation. We are very excited for having this support of the Spanish Government and committed to a social…
New contribution of BLOODGENETICS and UIC to ferritin diseases. One gene five diseases: hereditary hyperferritinemia with cataracts, benign hyperferritinemia, neuroferritinopathy, L-ferritin deficiency dominant, L-ferritin deficiency recessive. Follow the link to read the article: https://www.mdpi.com/1424-8247/12/1/17
BLOODGENETICS has been awarded with two contracts from the Spanish Ministry of Economy and Competitiveness: Postdoctoral position Torres Quevedo for three years Industrial Doctorate for four years
Accepted Publication in Haematologica Journal (impact factor: 9.090) with contribution from BLOODGENETICS The manuscript: «The phenotypic spectrum of germline YARS2 variants: from sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2» by Lisa G. Riley and colleagues has recently been accepted in the prestigious journal Haematologica. This work is a collaboration of researchers…
Dr. Mayka Sanchez (Josep Carreras Leukemia Research Institute and cofounder of BloodGenetics) held a seminar on April 4th at Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, in collaboration with the Unit of Hematology, Oncology and Hematopoietic Transplantation with the title “Hematological and neurological diseases due to homeostatic dysfunction of iron metabolism” Synopsis…
BLOODGENETICS at the I Genetic Interhospital Conference of Catalonia The BloodGenetics team will attend the I Interhospital Conference of Catalonia to be held at the Hospital de Sant Pau (Barcelona) on November 27th. During the conference we will participate in the roundtable in which the company-hospital relationship will be discussed. Also we will announce our…
BloodGenetics’s recapitalization round We are looking for investors. Held stocks of the Company from 2000€. If you are interested, please contact info@bloodgenetics.com and we will send you our Business Plan.
BLOODGENETICS at EHA22- Madrid 2017 BloodGenetics team attended the 22nd European Hematology Association (EHA22) International congress in Madrid on 22-25th June 2017. During this meeting, Dr. Tornador and Dr. Sanchez promote the company with a dinner at the restaurant “ La Zamorana” (very good food and very nice restaurant private room!) attended by medical doctors,…